Celldex Therapeutics Shares Down 38.0% Since SmarTrend's Sell Call (CLDX)

SmarTrend identified a Downtrend for Celldex Therapeutics (NASDAQ:CLDX) on July 27th, 2015 at $23.92. In approximately 1 month, Celldex Therapeutics has returned 38.03% as of today's recent price of...